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Abstract
Introduction: It has been indicated that disturbances in the production of certain pro-inflammatory cytokines might contribute to the 
development of osteoporosis in girls with anorexia nervosa (AN). The aim of the study was to determine whether girls with AN exhibited 
a relationship between IL-1β, IL-6, TNF-α, bone turnover markers (OC and CTx), OPG, sRANKL, and the OPG/sRANKL ratio.
Material and methods: Serum IL-1β, IL-6, TNF-α, OC, CTx, OPG, and sRANKL were determined by ELISA in 59 girls with AN and in 
17 healthy counterparts, aged 13 to 17 years. 
Results: Girls with AN showed significant reduction in body weight, BMI, BMI-SDS, and Cole index compared to the controls. These 
changes were associated with a significant increase in IL-1β, IL-6, TNF-α, OPG, and sRANKL concentrations and a decrease in bone 
markers and the OPG/sRANKL ratio. Significant negative correlations were found between BMI, the Cole index and CTx, OPG (girls 
with AN); between BMI and OC, CTx as well as the Cole index and CTx (the control group — C); between BMI, the Cole index and IL-β1, 
IL-6, TNF-α, CTx in all study participants (group AN+C). The combined group AN+C also exhibited positive correlation between BMI, 
the Cole index, and the OPG/sRANKL ratio. Girls with AN showed positive correlations between IL-1β, IL-6, and CTx as well as between 
TNF-α and sRANKL whereas the correlation between TNF-α and the OPG/sRANKL ratio was negative (IL-6 and IL-1β were identified 
to be independent predictors of CTx, TNF-α and IL-6 independently predicted sRANKL while TNF-α, IL-6, and IL-1β were independ-
ent predictors of the OPG/sRANKL ratio). The control participants exhibited negative correlations between IL-1β and OPG and positive 
correlations between IL-1β and sRANKL (IL-1β was found to be an independent predictor of OPG and sRANKL). In the AN+C group, 
IL-1β correlated negatively with OC and OPG and positively with sRANKL, while IL-6 and TNF-α positively correlated with CTx (IL-6 
and TNF-α turned out to be independent predictors of CTx, IL-1β of OPG while IL-6, TNF-α, and IL-1β were independent predictors 
of sRANKL and the OPG/sRANKL ratio).
Conclusions: The relationship between the nutritional status and IL-1β, IL-6, and TNF-α concentrations as well as bone status indicators 
seems to indicate that abnormalities observed regarding the concentrations of pro-inflammatory cytokines and bone remodelling in girls 
with AN might result from malnutrition. Correlations between IL-1β, IL-6, TNF-α, bone markers, OPG, its ligand sRANKL, and/or the 
OPG/sRANKL ratio suggest potential involvement of these cytokines in the mechanism underlying the lack of the expected bone mineral 
density increase in adolescent girls.  (Endokrynol Pol 2015; 66 (4): 313–321)
Key words: anorexia nervosa; girls; pro-inflammatory cytokines; bone metabolism; OPG; sRANKL
Streszczenie
Wstęp: Istnieją sugestie, że zaburzenia w wytwarzaniu niektórych cytokin prozapalnych mogą współuczestniczyć w mechanizmie 
prowadzącym do rozwoju osteoporozy u dziewcząt z jadłowstrętem psychicznym (AN, anorexia nervosa). Celem pracy było wykazanie, 
czy u dziewcząt z AN istnieje związek między IL-1β, IL-6, TNF-α, markerami obrotu kostnego (OC i CTx), OPG, sRANKL i wskaźnikiem 
OPG/sRANKL.
Materiał i metody: U 59 dziewcząt z AN i 17 zdrowych w wieku 13–17 lat oceniono stężenia IL-1β, IL-6, TNF-α, OC, CTx, OPG i sRANKL 
w surowicy metodą ELISA. 
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Introduction
It has been widely acknowledged that osteoporosis is 
a common complication of AN [1, 2]. Its aetiology is mul-
tifactorial. Well-documented disturbances in the produc-
tion, release, and action of several osteotropic agents, 
mainly hormones and cytokines (including some pro-
inflammatory cytokines), such as: interleukin (IL)-1β, 
IL-6, and tumour necrosis factor α (TNF-α) [3–8], might 
play a role in the mechanism leading to either a decrease 
or lack of the expected increase in bone mineral density 
(BMD) during adolescence [1]. 
Studies estimating IL-1β, IL-6, and TNF-α produc-
tion in patients with AN can be divided into two 
categories [3, 8]. The first category concentrates on 
in vitro  studies evaluating spontaneous or mitogen-
induced secretion of the above mentioned cytokines 
from peripheral blood mononuclear cells, the other 
concerns studies involving measuring their concentra-
tions in body fluids of the AN patients and/or adipose 
tissue cytokine expression [3, 8]. However, the obtained 
results have not always been clear, which makes it dif-
ficult to form any final conclusions. The most significant 
differences were reported regarding the levels of circu-
lating pro-inflammatory cytokines. Some researchers 
found an increase in circulating IL-1β, IL-6, or TNF-α 
in patients with AN compared to healthy individuals 
[9–14]. Others did not find significant differences in the 
concentrations of these cytokines between the study 
and control groups [15–19]. Nevertheless, others noted 
that serum TNF-α levels were undetectable in patients 
and controls [9, 20–25], while IL-6 concentrations were 
subnormal [25]. The majority of the investigations were 
carried out in adults, especially women [3, 8]; only a few 
studies comprised girls with AN [14, 19, 24–26]. After 
refeeding, the concentrations of IL-1β, IL-6, and TNF-α 
usually returned to levels characteristic of normal-
Wyniki: U dziewcząt z AN wykazano istotne obniżenie masy ciała, BMI, BMI-SDS oraz wskaźnika Cole’a w porównaniu z grupą kontrolną. 
Zmianom tym towarzyszył istotny wzrost stężeń IL-1β, IL-6, TNF-α, OPG, sRANKL przy zmniejszonym stężeniu markerów kostnych i 
obniżonym wskaźniku OPG/sRANKL. Wykazano ujemną korelację między wskaźnikami BMI i Cole’a a CTx i OPG (dziewczęta z AN); 
między BMI a OC i CTx oraz między wskaźnikiem Cole’a a CTx (grupa kontrolna — C); między wskaźnikami BMI i Cole’a a IL-β1, IL-
6, TNF-α, CTx (u wszystkich badanych łącznie: grupa AN+C). W grupie AN+C wskaźniki BMI i Cole’a korelowały ponadto dodatnio 
z wskaźnikiem OPG/sRANKL. U dziewcząt z AN stwierdzono dodatnią korelację między IL-1β i IL-6 a CTx, a także między TNF-α a 
sRANKL oraz ujemną między TNF-α a wskaźnikiem OPG/sRANKL (udokumentowano, że IL-6 i IL-1β są niezależnymi predyktorami dla 
CTx, TNF-α i IL-6 dla sRANKL a TNF-α, IL-6 i IL-1β dla wskaźnika OPG/sRANKL). W grupie kontrolnej IL-1β korelowała ujemnie z OPG 
a dodatnio z sRANKL (stwierdzono, że IL-1β jest niezależnym predyktorem dla OPG i sRANKL). W grupie AN+C zanotowano ujemną 
korelację między IL-1β a OC i OPG, a dodatnią między IL-1β a sRANKL oraz między IL-6 i TNF-α a CTx (wykazano, że IL-6 i TNF-α są 
niezależnymi predykatorami dla CTx, IL-1β dla OPG a IL-6, TNF-α i IL-1β dla sRANKL i wskaźnika OPG/sRANKL).
Wnioski: Wykazana zależność między stopniem odżywienia a stężeniami IL-1β, IL-6, TNF-α oraz wykładnikami stanu kośćca może 
świadczyć o tym, że przyczyną obserwowanych nieprawidłowości w stężeniach badanych cytokin prozapalnych i przebudowie 
tkanki kostnej u dziewcząt z AN może być niedożywienie. Istnienie powiązań między stężeniami IL-1β, IL-6, TNF-α a markerami 
kostnymi, OPG, jej liganden sRANKL i/lub wskaźnikiem OPG/sRANKL wskazuje na możliwy współudział wymienionych cyto-
kin w mechanizmie prowadzącym do braku oczekiwanego wzrostu gęstości mineralnej kości u dziewcząt w okresie dorastania. 
(Endokrynol Pol 2015; 66 (4): 313–321)
Słowa kluczowe: jadłowstręt psychiczny; dziewczęta; cytokiny prozapalne; metabolizm kostny; OPG; sRANKL 
weight controls [9, 10, 20, 21, 24]. However, this finding 
was not confirmed by other investigators [3, 16].
In vitro studies revealed that pro-inflammatory 
cytokines such as IL-1, IL-6, and TNF-α are important 
regulatory determinants of bone remodelling [27–30]. It 
has been found that osteoblasts express IL-1 receptors. 
Interleukin-1 stimulates the proliferation of osteoblast 
precursors and, depending on local concentration, may 
stimulate or inhibit collagen and alkaline phosphatase 
synthesis. IL-1 also inhibits the synthesis of osteocalcin 
(OC), stimulates bone tissue resorption, and promotes 
the synthesis and secretion of collagenase by an osteo-
blastic cell line. It activates mature osteoclasts and stim-
ulates the recruitment and differentiation of precursor 
cells [27]. IL-1-induced stimulation of osteoclastogenesis 
occurs indirectly via enhanced expression of receptor 
activator of nuclear factor-kB ligand (RANKL) in osteo-
blasts and marrow stromal cells [31–33]. Interleukin-6 
is a protein synthesised by lymphocytes and other cell 
types including osteoblasts and osteoclasts. Small doses 
of this cytokine stimulate the recruitment of osteoclast 
precursors while large doses increase osteoclast activ-
ity. Interleukin-6 stimulates osteoclastogenesis and 
enhances the action of parathyroid hormone-related 
protein (PTHrP) [27]. Liu et al. [34] indicated that an 
interaction between prostaglandin E2 (PE2) and IL-6 
promotes osteoclast differentiation via the RANKL/ 
/RANK/osteoprotegerin (OPG) system. Sanchez et al. 
[35] found that IL-6 inhibited OPG expression but did 
not modify RANKL mRNA level, ultimately resulting 
in a decrease of the OPG/RANKL ratio and hence in-
creased bone resorption. TNF-α stimulates osteoblast 
precursor proliferation but inhibits their maturation 
through a decrease in the synthesis of type 1 collagen 
and alkaline phosphatase activity [27]. Through syner-
gistic interaction with IL-1, TNF-α stimulates the fusion 
of osteoclast precursors into multinucleated osteoclasts 
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in bone marrow cells in vitro; it also activates mature os-
teoclasts [27]. TNF-α enhances RANKL expression and 
bone resorption by osteoclasts [36–39]. The above data 
suggest that cytokines may regulate osteoclastogenesis 
not only directly, but also indirectly via the RANKL/ 
/RANK/OPG system [27–39]. Through an increase in 
the expression of RANKL and/or a decrease in OPG 
expression, IL-1β, IL-6, or TNF-α may suppress the 
OPG/RANKL ratio resulting in enhanced bone resorp-
tion [27–39]. 
The results of in vitro investigations also indicate that 
some adipocyte-secreted factors, including the above-
mentioned pro-inflammatory cytokines, might modify 
the balance of OPG/RANKL [40–42]. It was shown that 
human adipocytes regulated the expression of OPG and 
RANKL in human osteoblastic cell lines in vitro. They 
inhibited and stimulated the expressions of RANKL 
and OPG, respectively [40, 42]. The OPG/RANKL ratio 
in primary human preosteoblasts increased (mRNA 
and protein) when stimulated with adipocyte-secreted 
factors. Osteoblasts that were pre-stimulated with 
adipocyte-secreted factors inhibited the formation of 
osteoclasts [42]. 
Only a few researchers have studied the relationship 
between pro-inflammatory cytokines and bone status 
in patients with AN [25, 43]. Increased concentrations 
of OC and the C-terminal telopeptide of type I collagen 
α 1 chain (CTx) and reduced OPG levels observed in 
young women with AN and depressive disorder were 
associated with a significant increase in TNF-α level 
[43]. TNF-α concentrations were positively correlated 
with CTx and negatively with OPG [43]. However, in 
adolescent girls with AN, IL-1β and TNF-α levels were 
undetectable, IL-6 concentrations markedly lowered, 
bone formation markers suppressed (bone-specific 
alkaline phosphatase — BSAP and OC), and resorption 
marker (N-terminal telopeptide of type I collagen α 1 
chain — NTx) increased [25]. These inconsistencies re-
garding a potential relationship between bone markers 
in patients with AN caused us to undertake a research 
project in this area. 
The aim of the study was to determine whether girls 
with AN showed any relationships between IL-1β, IL-
6, TNF-α, bone turnover markers (OC and CTx), OPG, 
sRANKL, and the OPG/sRANKL ratio.
Material and methods
The study comprised 59 girls aged 13 to 17 years, hospi-
talised at the Paediatric Endocrinology Division of the 
Paediatric Department in Zabrze, who, following an 
examination by paediatricians and a psychiatrist, were 
diagnosed with AN based on the American Psychiatric 
Association’s classification and diagnostic tool, i.e. the 
DSM-IV of 1994. Girls with AN underwent all tests dur-
ing the first three days of hospital stay, i.e. prior to the 
launch of therapy. All other somatic or mental disorders 
that might lead to cachexia were ruled out. The mean 
age of the AN patients was 15.27 ± 1.62 years (Table I). 
All had primary or secondary amenorrhoea. The du-
ration of the disease was 3 to 60 months. The control 
group consisted of 17 healthy regularly menstruating 
girls (mean age 15.71 ± 1.68 years) with no endocrine 
or other disorders that could affect bone tissue metabo-
lism; they were all schoolgirls from the city of Zabrze 
who volunteered to participate in the study. 
The height and body weight of all participants were 
measured, and their body mass index (BMI; weight/ 
/height2) and BMI standard deviation score (BMI-SDS) 
calculated. BMI-SDS was assessed using gender- and 
Table I. Mean values of age, body weight, height, body 
mass index (BMI), standard deviation score for BMI 
(BMI-SDS), the Cole index, mean serum levels of selected 
pro-inflammatory cytokines, osteocalcin (OC), C-terminal 
telopeptide of type I collagen α 1 chain (CTx), osteoprotegerin 
(OPG), soluble receptor activator of nuclear factor-kB ligand 
(sRANKL), and mean value of the OPG/sRANKL ratio in girls 
with anorexia nervosa and in the control group
Tabela I. Średni wiek, masa ciała, wzrost, wskaźnik masy 
ciała (BMI), odchylenie standardowe dla BMI (BMI-SDS), 
wskaźnik Cole’a, średnie stężenia wybranych cytokin 
prozapalnych, osteokalcyny (OC), karboksyterminalnego 
usieciowanego telopeptydu łańcucha α 1 kolagenu typu I 
(CTx), osteoprotegeryny (OPG), rozpuszczalnego ligandu 
receptora aktywatora czynnika jądrowego-kB (sRANKL) 
oraz wartość wskaźnika OPG/sRANKL u dziewcząt 
z jadłowstrętem psychicznym i w grupie kontrolnej
Variables Groups
Anorexia nervosa
(n = 59)
Control 
(n = 17)
Age (years) 15.27 ± 1.62 15.71 ± 1.68
Height [m] 1.62 ± 0.06 1.66 ± 0.04
Body weight [kg] 39.17 ± 3.59* 55.27 ± 6.80
BMI [kg/m2] 15.27 ± 1.84* 20.38 ± 2.19
BMI-SDS –2.52 ± 1.10* 0.05 ± 1.01
Cole index (%) 78.31 ± 0.99* 100.17 ± 0.86
IL-1β [pg/mL] 9.77 ± 1.31* 4.43 ± 1.69
IL-6 [pg/mL] 3.52 ± 0.69* 2.12 ± 0.94
TNF-α [pg/mL] 5.55 ± 1.23* 2.51 ± 0.70
OC [μmol/L] 0.92 ± 0.73* 3.65 ± 2.31
CTx [nmol/L] 7.21 ± 0.91* 8.06 ± 0.87
OPG [pmol/L] 5.40 ± 0.89* 3.58 ± 1.30
sRANKL [pmol/L] 0.39 ± 0.03* 0.22 ± 0.01
OPG/sRANKL ratio 12.85 ± 1.43* 16.27 ± 1.08
*p ≤ 0.05 vs. control group
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age-specific BMI percentiles developed for the Polish 
population by Palczewska et al. [44]. The mean body 
weight of girls with AN was 39.17 ± 3.59 kg, mean BMI 
was 15.27 ± 1.84 kg/m2, and the mean BMI-SDS was –2.52 
± 1.10. The Cole index was also calculated, which reflects 
the nutritional status of an individual and encompasses 
the following categories: < 75%: wasting; 75–85%: 
undernourished; 85–90% mildly undernourished; 
90–100% adequately nourished; and > 110% overnour-
ished [acc. to 45]. The mean value of the Cole index in 
our AN patients was 78.31 ± 0.90%. The mean body 
weight of the control participants was 55.27 ± 6.80 kg, 
BMI was 20.38 ± 2.19 kg/m2, BMI-SDS was –0.05 ± 1.01, 
and the Cole index was 100.17 ± 0.86 % (Table I).
On the day of the examination the girls did not 
report any complaints; none of them suffered from 
acute infection during the preceding month. Blood 
samples (8 mL) for the determination of IL-1β, IL-6, 
TNF-α, and bone markers, i.e. OC (bone formation 
marker) and the CTx (bone resorption marker) as 
well as OPG and its soluble ligand sRANKL, were 
collected between 08.00 and 09.00 after a 12-hour fast. 
Centrifuged serum was frozen and stored at –75°C 
until assay. Determinations of the concentrations of 
selected pro-inflammatory cytokines, OC, CTx, OPG, 
and sRANKL were performed by High Sensitivity 
Human ELISA kits: IL-1β (Quantikine R&D System, 
Inc., USA), IL-6 (BioVendor — Laboratorni medicina 
a.s., Czech Republic), TNF-α (eBioscience, Austria), 
OC (DSL Inc., USA), CTx (Nornic Bioscience Diagnos-
tics A/S, Denmark), OPG, and sRANKL (Biomedica, 
Austria). The respective sensitivity intra- and inter-
assay errors were: 1 pg/mL, 4.8 and 5.6% for IL-1β; 
0.81 pg/mL, 4.4 and 9.1% for IL-6; 0.13 pg/mL, 8.5 and 
9.8% for TNF-α; 0.05 μmol/L, 5.8 and 7.3% for OC; 
0.08 nmol/L, 5.2 and 6.7% for CTx; 0.14 pmol/L, 7 and 
7.5% for OPG; 0.04 pmol/L, 5 and 7% for sRANKL. 
The database was prepared using Excel 2000 (Mi-
crosoft Corporation). Statistical analysis was carried 
out with Statistica 10 for Windows (StatSoft Inc., USA). 
The t-test was used to determine the significance of in-
tergroup differences (normal distribution of variables). 
In the case of non-normal distribution, the significance 
was tested using the Mann-Whitney U test. The re-
lationships between the BMI, the Cole index, IL-1β, 
IL-6, TNF-α, OC, CTx, OPG, sRANKL, and the OPG/ 
/sRANKL ratio in girls with AN, control participants (C), 
and the combination group of AN+C were analysed 
using Spearman’s correlation. The level of significance 
was set at p ≤ 0.05.
Stepwise regression was used to determine whether 
and which of the investigated cytokines were inde-
pendent predictors of bone markers, cytokines of the 
RANKL/RANK/OPG system, and the OPG/sRANKL 
ratio (model entry was set at p = 0.05, and model exit 
at p = 0.05). 
The study was approved by the Bioethics Com-
mittee of the Silesian Medical University in Katowice 
(KNW/0022/KB1/105/09). The patients and their parents 
or guardians gave their informed consent to participate 
in the study. 
Results
Mean body weight, BMI, BMI-SDS, and the Cole index 
were significantly lower and mean serum IL-1β, IL-6, 
and TNF-α significantly higher in girls with AN com-
pared to healthy controls. The changes in the concentra-
tions of the pro-inflammatory cytokines were associated 
with considerable suppression of the mean serum levels 
of bone markers (OC and CTx) and elevation of the 
mean OPG and sRANKL levels compared to healthy 
participants with normal body weight. The mean value 
of the OPG/sRANKL ratio was significantly lower in 
girls with AN than in the control group (Table I). 
Girls with AN exhibited a negative and significant 
correlation between BMI, the Cole index, and CTx 
as well as OPG. In the control group, a negative and 
significant correlation was revealed between BMI and 
OC, CTx as well as between the Cole index and CTx 
(Table II). In the combined AN+C group, BMI and the 
Cole index correlated negatively and significantly with 
serum IL-β1, IL-6, TNF-α, and CTx and positively with 
the OPG/sRANKL ratio (Table II).
In girls with AN, IL-1β and IL-6 correlated positively 
and significantly with CTx. TNF-α was positively and 
significantly correlated with sRANKL and negatively with 
the OPG/sRANKL ratio. IL-6 and IL-1β were shown to be 
independent predictors of CTx (R2 = 0.1105, p = 0.048); 
TNF-α and IL-6 turned out to be independent predictors 
of sRANKL (R2 = 0.1684, p = 0.013) while TNF-α, IL-6, and 
IL-1β were independent predictors of the OPG/sRANKL 
ratio (R2 = 0.1706, p = 0.034) (Table III).
In the control group IL-1β was negatively and 
significantly correlated with OPG and positively with 
sRANKL. IL-1β turned out to be an independent pre-
dictor of OPG (R2 = 0.2552, p = 0.044) and sRANKL 
(R2 = 0.1998, p = 0.049) (Table III). 
In the combined AN+C group, IL-1β correlated 
negatively with OC and OPG and positively with 
sRANKL while IL-6 and TNF-α were positively cor-
related with CTx. IL-6 and TNF-α were independent 
predictors of CTx (R2 = 0.0407, p = 0.049). IL-1β turned 
out to be an independent predictor of OPG (R2 = 0.0598, 
p = 0.047) while IL-6, TNF-α, and IL-1β were shown 
to be independent predictors of sRANKL (R2 = 0.1331, 
p = 0.032) and the OPG/sRANKL ratio (R2 = 0.1079, 
p = 0.041) (Table III).
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Discussion
Girls with AN usually exhibit suppression of bone for-
mation and resorption markers, which correlates with 
BMI and/or BMD, and indicates a decrease in bone 
turnover [46–63]. It was also observed that an increase 
in serum OPG correlated negatively with BMI and/or 
BMD [51, 58–63]. However, several authors reported 
a slight or significant increase in bone resorption mark-
ers in patients with AN, which was associated with 
a significant decrease in bone formation markers [1]. 
The suppression of bone resorption markers in girls 
with AN observed by the majority of researchers might 
indicate an inhibiting effect of high OPG concentrations 
on osteoclast activity [51]. Consistent with our previ-
ous results [58–63], the present findings also show a 
decrease in serum bone markers (OC and CTx) as well 
as a significant increase in OPG and sRANKL, associated 
with a noticeable decrease in the OPG/sRANKL ratio. 
The high correlation between CTx and/or OC and the 
OPG/sRANKL ratio unassociated with or associated 
with a moderate correlation between bone markers 
and OPG and/or sRANKL seems to suggest that it is 
the OPG/RANKL ratio rather than OPG and/or RANKL 
alone that determines osteoclast differentiation and 
activation as well as apoptosis thereof [58–63]. The low 
values of the OPG/sRANKL ratio paralleled by high 
OPG and sRANKL concentrations confirmed in the 
present study along with some degree desynchronisa-
tion of the relationships between these cytokines and 
bone formation and resorption markers [58–63] indicate 
that girls with AN might suffer from a compromise 
in the mechanism which controls bone remodelling 
and/or mechanism compensating for enhanced bone 
turnover. Adolescent females with AN, examined by 
Munoz-Calvo et al. [64], exhibited a significant decrease 
in the OPG/RANKL ratio correlated with an increase in 
RANKL as well as a positive and significant correlation 
between the OPG/RANKL ratio and BMD. However, 
the researchers did not observe a significant OPG in-
crease in the sera of girls with AN or any relation-
ships between OPG, RANKL, and BMD. Hence, they 
concluded that the decrease in the OPG/RANKL ratio 
only partly explained the increased bone loss observed 
in their study population with AN. 17β-oestradiol is 
known to be a major regulator of bone metabolism and 
BMD in women and girls suffering from AN. However, 
both OPG and RANKL, and OPG in particular, are 
regulated not only by 17β-estradiol, but also by other 
hormones and cytokines (maybe also pro-inflammatory 
cytokines), whose effect might be similar or opposite to 
that of 17β-estradiol [27]. It has been demonstrated that 
pro-inflammatory cytokines influence the bone tissue 
directly and/or indirectly, via the RANKL/RANK/OPG 
system [27–39]. Since it has been documented that IL-1β, 
IL-6, and TNF-α stimulate bone resorption both in vitro 
and in vivo [27–30], it seems reasonable to presume that 
any potential disturbances in the production of these 
cytokines in patients with AN might play a role in the 
development of osteoporosis.
Numerous researchers investigated the concentra-
tions of pro-inflammatory cytokines in patients with 
AN. However, the obtained results were not always 
consistent. Several authors reported normal [11, 17, 18], 
decreased [25], or increased IL-1β levels [10, 14]; normal 
[11, 15, 17–19] or increased IL-6 concentrations [1, 9, 12] 
as well as normal [11, 17–19] or increased TNF-α levels 
[12, 13, 16], compared to healthy weight controls. Our 
female adolescents with AN exhibited a significant in-
Table II. Correlation between body mass index (BMI), the 
Cole index and the selected pro-inflammatory cytokines, 
osteocalcin (OC), C-terminal telopeptide of type I collagen α 1 
chain (CTx), osteoprotegerin (OPG), soluble receptor activator 
of nuclear factor-kB ligand (sRANKL), and the OPG/sRANKL 
ratio in girls with anorexia nervosa (AN), in the control group 
(C), and in all girls (AN + C)
Tabela II. Korelacja między wskaźnikiem masy ciała 
(BMI), wskaźnikiem Cole’a a wybranymi cytokinami 
prozapalnymi, osteokalcyną (OC), karboksyterminalnym 
usieciowanym telopeptydem łańcucha α 1 kolagenu typu I 
(CTx), osteoprotegeryną (OPG), rozpuszczalnym ligandem 
receptora aktywatora czynnika jądrowego-kB (sRANKL) 
i wartościami wskaźnika OPG/sRANKL u dziewcząt 
z jadłowstrętem psychicznym (AN), w grupie kontrolnej (C) 
i u wszystkich dziewcząt łącznie (AN+C) 
Variables Values of correlation coefficients
AN  
(n = 59)
C  
(n = 17)
AN+C  
(n = 76)
BMI  
[kg/m2]
IL-β1 [pg/mL] 0.098 0.144 –0.576*
IL-6 [pg/mL] –0.174 –0.227 –0.552*
TNF-α [pg/mL] 0.191 0.144 –0.478*
OC [μmol/L] 0.206 –0.533* –0.186
CTx [nmol/L] –0.379* –0.483* –0.329*
OPG [pmol/L] –0.266* –0.067 –0.069
sRANKL [pmol/L] 0.147 0.028 –0.040
OPG/sRANKL ratio 0.145 –0.015 0.248*
Cole index 
(%)
IL-β1 [pg/mL] 0.025 –0.046 –0.565*
IL-6 [pg/mL] –0.127 –0.222 –0.449*
TNF-α [pg/mL]↓ 0.094 –0.046 –0.459*
OC [μmol/L] 0.207 –0.380 –0.123
CTx [nmol/L] –0.326* –0.517* –0.321*
OPG [pmol/L] –0.300* 0.189 –0.072
sRANKL [pmol/L] 0.171 –0.019 –0.007
OPG/sRANKL ratio 0.114 0.020 0.235*
*p ≤ 0.05 — statistically significant values of correlation coefficients
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crease in serum IL-1β (similar to the study participants 
of Allende et al. [10] and Ziora et al. [14]), IL-6 (similar 
to the study participants of Pomeroy et al. [9], Kahl et al. 
[12], and Misra & Klibansky [1]), and TNF-α (similar to 
study participant of Nakai et al. [11], Kahl et al. [12], and 
Angello et al. [13]). The above-mentioned inter-study 
discrepancies in IL-1β, IL-6, or TNF-α levels in patients 
with AN might be due to differences in group size; the 
number of participants was often quite small [3], which 
clearly affected the results of statistical analyses. Also, 
determinations were made using different biological 
materials and methods of unequal sensitivity and 
specificity. Some authors determined pro-inflammatory 
cytokine levels using ELISA [10, 20, 65] whereas others 
chose RIA [16, 18, 66] or IRMA [16]. These methods, as 
explained in their respective instruction manuals, allow 
the measurement of serum immunoradioactivity and 
detection of biologically inactive cytokines or their frag-
ments. Others tested the biological activity of cytokines 
using bioassays [3, 8, 9, 23]. It cannot be ruled out that 
discrepancies in IL-1β, IL-6, or TNF-α levels might also 
be associated with different times of sample collection. 
Due to circadian patterns in certain cytokines secretion, 
e.g. TNF-α [67, 68], it is important that material sam-
pling should be scheduled at the same time each day. 
In our study, cytokine determinations were made with 
ultrasensitive, latest-generation ELISA, which made 
it possible to measure biologically active cytokines, 
especially in reference to IL-1β. Blood samples for the 
determination of pro-inflammatory cytokines and bone 
Table III. Correlationa between the selected pro-inflammatory cytokines, osteocalcin (OC), C-terminal telopeptide of type I 
collagen α 1 chain (CTx), osteoprotegerin (OPG), soluble receptor activator of nuclear factor-kB ligand (sRANKL), and the 
OPG/sRANKL ratio in girls with anorexia nervosa (AN), in the control group (C) and in all girls studied (AN+C)
Tabela III. Korelacjaa między wybranymi hormonami tkanki tłuszczowej, osteokalcyną (OC), karboksyterminalnym 
usieciowanym telopeptydem łańcucha α 1 kolagenu typu I (CTx), osteoprotegeryną (OPG), rozpuszczalnym ligandem 
receptora aktywatora czynnika jądrowego-kB (sRANKL) i wartościami wskaźnika OPG/sRANKL u dziewcząt z jadłowstrętem 
psychicznym (AN), w grupie kontrolnej (C), i u wszystkich dziewcząt łącznie (AN + C) 
Variables Bone markers Cytokines of RANKL/RANK/OPG 
system
OPG/sRANKL 
ratio
Groups
OC 
[μmol/L]
CTx 
[nmol/L]
OPG  
[pmol/L]
sRANKL  
[pmol/L]
IL-1β [pg/mL] –0.040 0.262* –0.092 0.107 –0.106 AN
(n = 59)IL-6 [pg/mL] 0.081 0.271* 0.072 –0.216 –0.109
TNF-α [pg/mL] 0.138 –0.019 0.104 0.355* –0.274*
Stepwise regression modelb
R2
p
– Il-6
IL-1β
0.1105
0.048
– TNF-α
IL-6
0.1684
0.013
TNF-α
IL-6
IL-1β
0.1706
0.034
IL-1β [pg/mL] 0.217 0.097 –0.553* 0.487* –0.189 C
(n = 17)IL-6 [pg/mL] –0.161 –0.133  0.183 0.213 –0.053
TNF-α [pg/mL] –0.202 0.041  0.159 0.061 –0.111
Stepwise regression modelb
R2
p
– – IL-1β
0.2552
0.044
IL-1β
0.1998
0.049
–
IL-1β [pg/mL] –0.234* 0.181 –0.289  0.290* –0.212 AN+C
(n = 76)IL-6 [pg/mL] 0.178 0.219* 0.049 0.152 –0.201
TNF-α [pg/mL] 0.156 0.269* 0.121 0.127 0.193
Stepwise regression modelb
R2
p
– IL-6
TNF-α
0.0407
0.049
IL-1β
0.0598
0.047
IL-6
TNF-α
IL-1β
0.1331
0.032
IL-6
TNF-α
IL-1β
0.1079
0.041
*p ≤ 0.05 — statistically significant values of correlation coefficients; aDisplayed value represents the model variance accounted for by these parameters; bParameters 
entering the stepwise regression model
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markers were always collected between 08.00 and 09.00 
after a 12-hour fast. 
Our findings, similar to previously reported results 
of other researchers [14, 19], indicate a significant cor-
relation between the investigated cytokines and BMI 
and the Cole index in girls with AN and in control 
participants, when analysed collectively (AN+C), 
most probably due to considerable differences in body 
weight. Separate analyses of AN and control groups did 
not reveal such relationships. On the other hand, BMI 
and/or the Cole index correlated significantly with OC, 
CTx, and/or OPG in all study groups, i.e. groups with 
AN and the control group, when analysed separately, 
and AN+C analysed collectively. All girls also exhibited 
a significant correlation between BMI, the Cole index, 
and the OPG/sRANKL ratio. The relationship between 
the nutritional status and IL-1β, IL-6, and TNF-α levels 
as well as the above-mentioned bone status indices 
might suggest that malnutrition could be the under-
lying cause of abnormalities observed both in pro-
inflammatory cytokines and bone remodeling. 
Our results also seem to demonstrate relationships 
between selected pro-inflammatory cytokines and cer-
tain bone status indices. IL-1β was negatively correlated 
with OPG and positively with sRANKL in healthy girls 
with normal body weight. It also turned out to be an 
independent predictor of OPG and sRANKL. Our pa-
tients with AN showed a positive correlation between 
IL-1β and CTx. IL-1β was an independent predictor 
of CTx and the OPG/sRANKL ratio. However, in the 
combined group (AN+C), IL-1β was negatively corre-
lated with OC and OPG, and positively with sRANKL. 
Interleukin-1β turned out to be an independent pre-
dictor of OPG, sRANKL, and the OPG/sRANKL ratio. 
Previous in vitro investigations revealed that, depend-
ing on its local concentration, IL-1β may stimulate or 
inhibit osteoblasts through specific receptors [27]. It also 
stimulates bone resorption via the RANKL/RANK/OPG 
system [31–33]. In vitro investigations demonstrated that 
IL-1β enhanced the expression of the RANKL gene in 
osteoblasts and marrow stromal cells leading to a shift 
in the OPG/sRANKL ratio toward a functional excess of 
sRANKL, and, consequently, increased bone resorption 
[31–33]. The negative and positive correlation between 
IL-1β and OPG and sRANKL, respectively, revealed in 
our study, seems to indicate that IL-1β might be capable 
of changing not only sRANKL but also OPG expression. 
However, some direct or indirect influence of other, for 
example hormone-related factors (such as oestrogen 
deficiency), on OPG expression cannot be excluded [27]. 
Similar to our findings, Misra & Klibansky [1] also 
observed increased IL-6 concentrations in AN; how-
ever, a stepwise regression analysis revealed that this 
cytokine was not an independent predictor of BMD or 
bone resorption markers in their patients. Our results 
showed a positive correlation only between IL-6 and 
CTx in the combination (AN+C) and AN groups, but 
not in the control. However, a stepwise regression 
analysis demonstrated that IL-6 was an independent 
predictor of CTx, sRANKL, and the OPG/sRANKL ratio. 
Numerous researchers reported that IL-6 stimulated 
osteoclastogenesis in vitro [69]. The cytokine was also 
demonstrated to act as a regulator of bone resorption via 
the RANKL/RANK/OPG system [34, 35]. Sanchez et al. 
[35] suggested that although IL-6 did not influence the 
expression of RANKL, it inhibited OPG secretion, thus 
exerting a suppressive effect on the OPG/RANKL ratio. 
There is evidence that TNF-α enhances RANKL ex-
pression in vitro with resultant suppression of the OPG/ 
/RANKL ratio and stimulation of osteoclastic bone re-
sorption [27, 30, 36–39]. In young women with AN and 
a depressive disorder, an increase in serum OC and CTx 
and low OPG levels were associated with TNF-α eleva-
tion [43]. There was also a positive correlation between 
TNF-α and OPG. Regarding our study participants we 
found relationships between TNF-α and CTx and/or 
sRANKL and the OPG/sRANKL ratio in the AN and 
AN+C groups. In the AN+C group TNF-α correlated 
positively with CTx while in AN patients TNF-α was 
positively correlated with sRANKL and negatively with 
the OPG/sRANKL ratio. Moreover, in the AN group 
TNF-α turned out to be an independent predictor 
of sRANKL and the OPG/sRANKL ratio while in the 
AN+C group TNF-α turned out to be an independent 
predictor of CTx, sRANKL, and the OPG/sRANKL ratio. 
These findings seems to confirm the hypothesis on the 
potential role of this cytokine in the development of 
osteoporosis in patients with AN.
When considering the possible contribution of 
pro-inflammatory cytokines to osteoporosis in pa-
tients with AN, it should be kept in mind that the 
endocrine changes seen in these individuals including 
sex steroid suppression as well as enhanced cortisol 
and β-endorphin secretion might, on one hand, affect 
cellular immunity [3], and, on the other hand, modify 
bone remodelling via the RANKL/RANK/OPG system 
[27, 62]. Based on the results of in vitro investigations 
and our findings, this effect might be presumed to 
occur directly or indirectly via cytokines, also IL-1β, 
IL-6, or TNF-α. Oestrogens have been demonstrated 
to stimulate osteoblasts to express the OPG gene while 
suppression is caused by 1,25(OH)2D3, glucocorticoster-
oids and PTH [27, 28]. It is believed that the inhibition of 
the OPG gene by glucocorticosteroids and an increase 
in RANKL expression by these hormones might be 
among the important mechanisms that contribute to 
the development of osteoporosis — also in patients 
with AN. 
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Conclusions
The relationship between the nutritional status and IL-
1β, IL-6, TNF-α as well as bone status indicators seems 
to indicate that abnormalities in the concentrations of 
pro-inflammatory cytokines and bone remodelling ob-
served in AN patients might result from undernutrition. 
Correlations between IL-1β, IL-6, TNF-α, bone mark-
ers, OPG, its ligand sRANKL, and/or the OPG/sRANKL 
ratio suggest potential involvement of theses cytokines 
in the mechanism underlying the lack of the expected 
bone mineral density increase in adolescent girls. 
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